Currently holds a position at Intra-Cellular Therapies Inc
Position | Company | Period |
---|---|---|
Executive Vice President, General Counsel and Secretary | Intra-Cellular Therapies Inc | Jan. 1, 2019 - |
Senior Vice President, General Counsel, Secretary | Intra-Cellular Therapies Inc | July 1, 2014 - Dec. 1, 2018 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-11 | 2024-03-11 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,238
-100.0%
66.7082,575 USD |
1,238 -100.0% | 66.70 | 82,575 USD | |
2024-03-11 | 2024-03-11 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
6,107
-83.1%
65.82401,963 USD |
6,107 -83.1% | 65.82 | 401,963 USD | |
2024-03-11 | 2024-03-07 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
220
-100.0%
66.8114,698 USD |
220 -100.0% | 66.81 | 14,698 USD | |
2024-03-11 | 2024-03-07 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
12,912
-98.3%
66.14854,000 USD |
12,912 -98.3% | 66.14 | 854,000 USD | |
2024-02-27 | 2024-02-26 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
392
-100.0%
70.1327,491 USD |
392 -100.0% | 70.13 | 27,491 USD | |
2024-02-27 | 2024-02-26 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
7,215
-94.8%
69.54501,731 USD |
7,215 -94.8% | 69.54 | 501,731 USD | |
2024-02-27 | 2024-02-26 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
300
-3.8%
68.5420,562 USD |
300 -3.8% | 68.54 | 20,562 USD | |
2024-02-05 | 2024-02-02 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
714
-100.0%
67.1747,959 USD |
714 -100.0% | 67.17 | 47,959 USD | |
2024-02-05 | 2024-02-02 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
11,146
-94.0%
66.37739,760 USD |
11,146 -94.0% | 66.37 | 739,760 USD | |
2024-01-12 | 2024-01-11 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,486
-100.0%
67.80100,751 USD |
1,486 -100.0% | 67.80 | 100,751 USD | |
2024-01-12 | 2024-01-11 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
30,360
-95.3%
67.102,037,156 USD |
30,360 -95.3% | 67.10 | 2,037,156 USD | |
2024-01-12 | 2024-01-11 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
18,154
-36.3%
66.311,203,792 USD |
18,154 -36.3% | 66.31 | 1,203,792 USD | |
2023-11-14 | 2023-11-13 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
41,067
-100.0%
54.012,218,029 USD |
41,067 -100.0% | 54.01 | 2,218,029 USD | |
2023-03-13 | 2023-03-13 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
476
-100.0%
44.1521,015 USD |
476 -100.0% | 44.15 | 21,015 USD | |
2023-03-13 | 2023-03-13 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
6,868
-93.5%
44.99308,991 USD |
6,868 -93.5% | 44.99 | 308,991 USD | |
2023-03-13 | 2023-03-10 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
2,500
-100.0%
42.52106,300 USD |
2,500 -100.0% | 42.52 | 106,300 USD | |
2023-03-13 | 2023-03-10 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
14,208
-85.0%
43.20613,786 USD |
14,208 -85.0% | 43.20 | 613,786 USD | |
2023-02-22 | 2023-02-21 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
100
-100.0%
49.604,960 USD |
100 -100.0% | 49.60 | 4,960 USD | |
2023-02-22 | 2023-02-21 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,100
-91.7%
48.6853,548 USD |
1,100 -91.7% | 48.68 | 53,548 USD | |
2023-02-22 | 2023-02-21 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
643
-34.9%
47.2330,369 USD |
643 -34.9% | 47.23 | 30,369 USD | |
2023-02-22 | 2023-02-21 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
9,296
-83.5%
46.56432,822 USD |
9,296 -83.5% | 46.56 | 432,822 USD | |
2022-12-02 | 2022-12-01 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
22,796
-100.0%
53.481,219,130 USD |
22,796 -100.0% | 53.48 | 1,219,130 USD | |
2022-12-02 | 2022-12-01 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
27,204
-54.4%
53.941,467,384 USD |
27,204 -54.4% | 53.94 | 1,467,384 USD | |
2022-02-25 | 2022-02-24 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
4,188
-100.0%
51.62216,185 USD |
4,188 -100.0% | 51.62 | 216,185 USD | |
2022-02-25 | 2022-02-24 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
3,718
-47.0%
52.38194,749 USD |
3,718 -47.0% | 52.38 | 194,749 USD | |
2022-02-23 | 2022-02-22 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
4,550
-100.0%
54.98250,159 USD |
4,550 -100.0% | 54.98 | 250,159 USD | |
2022-02-23 | 2022-02-22 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
6,589
-59.2%
55.69366,941 USD |
6,589 -59.2% | 55.69 | 366,941 USD | |
2022-01-11 | 2022-01-10 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
4,380
-100.0%
40.12175,726 USD |
4,380 -100.0% | 40.12 | 175,726 USD | |
2022-01-11 | 2022-01-10 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
12,755
-74.4%
40.81520,532 USD |
12,755 -74.4% | 40.81 | 520,532 USD | |
2022-01-11 | 2022-01-10 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
2,504
-12.8%
41.74104,517 USD |
2,504 -12.8% | 41.74 | 104,517 USD | |
2021-12-23 | 2021-12-21 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
4,344
-100.0%
44.87194,915 USD |
4,344 -100.0% | 44.87 | 194,915 USD | |
2021-12-23 | 2021-12-21 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
8,690
-66.7%
45.74397,481 USD |
8,690 -66.7% | 45.74 | 397,481 USD | |
2021-12-23 | 2021-12-21 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
36,434
-73.7%
46.871,707,662 USD |
36,434 -73.7% | 46.87 | 1,707,662 USD | |
2021-12-23 | 2021-12-21 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
104,775
-67.9%
47.845,012,436 USD |
104,775 -67.9% | 47.84 | 5,012,436 USD | |
2021-12-23 | 2021-12-21 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
22,620
-12.8%
48.621,099,784 USD |
22,620 -12.8% | 48.62 | 1,099,784 USD | |
2021-02-22 | 2021-02-19 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,100
-100.0%
38.9142,801 USD |
1,100 -100.0% | 38.91 | 42,801 USD | |
2021-02-22 | 2021-02-19 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
10,039
-90.1%
39.28394,332 USD |
10,039 -90.1% | 39.28 | 394,332 USD | |
2021-01-12 | 2021-01-11 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,936
-100.0%
31.6561,274 USD |
1,936 -100.0% | 31.65 | 61,274 USD | |
2021-01-12 | 2021-01-11 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
17,702
-90.1%
32.07567,703 USD |
17,702 -90.1% | 32.07 | 567,703 USD | |
2021-01-05 | 2021-01-04 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
3,174
-100.0%
30.9498,204 USD |
3,174 -100.0% | 30.94 | 98,204 USD | |
2021-01-05 | 2021-01-04 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
12,986
-80.4%
31.39407,631 USD |
12,986 -80.4% | 31.39 | 407,631 USD | |
2020-11-19 | 2020-11-17 |
Intra-Cellular Therapies Inc
(ITCI)
|
S Sale |
3,761
-100.0%
27.95105,120 USD |
3,761 -100.0% | 27.95 | 105,120 USD | |
2020-11-19 | 2020-11-17 |
Intra-Cellular Therapies Inc
(ITCI)
|
S Sale |
75,664
-95.3%
27.602,088,326 USD |
75,664 -95.3% | 27.60 | 2,088,326 USD | |
2020-01-10 | 2020-01-09 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
19,638
-99.0%
26.16513,730 USD |
19,638 -99.0% | 26.16 | 513,730 USD | |
2020-01-08 | 2020-01-06 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
17,513
-98.9%
30.46533,446 USD |
17,513 -98.9% | 30.46 | 533,446 USD | |
2020-01-08 | 2020-01-06 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
3,945
-18.2%
29.80117,561 USD |
3,945 -18.2% | 29.80 | 117,561 USD | |
2020-01-03 | 2020-01-02 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
25
-11.6%
34.30858 USD |
25 -11.6% | 34.30 | 858 USD | |
2020-01-03 | 2020-01-02 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,200
-84.7%
33.2339,876 USD |
1,200 -84.7% | 33.23 | 39,876 USD | |
2020-01-03 | 2020-01-02 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
4,959
-77.8%
32.43160,820 USD |
4,959 -77.8% | 32.43 | 160,820 USD | |
2020-01-03 | 2020-01-02 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,623
-20.3%
31.8351,660 USD |
1,623 -20.3% | 31.83 | 51,660 USD | |
2019-01-08 | 2019-01-07 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
3,108
-94.2%
12.4238,601 USD |
3,108 -94.2% | 12.42 | 38,601 USD | |
2019-01-08 | 2019-01-04 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
5,398
-62.1%
11.8063,696 USD |
5,398 -62.1% | 11.80 | 63,696 USD | |
2019-01-08 | 2019-01-04 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
16,060
-64.9%
11.34182,120 USD |
16,060 -64.9% | 11.34 | 182,120 USD | |
2019-01-03 | 2019-01-02 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
7,807
-97.6%
11.0986,580 USD |
7,807 -97.6% | 11.09 | 86,580 USD | |
2018-01-05 | 2018-01-05 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,560
-5.7%
17.4927,284 USD |
1,560 -5.7% | 17.49 | 27,284 USD | |
2018-01-05 | 2018-01-04 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
2,660
-8.9%
15.7541,895 USD |
2,660 -8.9% | 15.75 | 41,895 USD | |
2017-01-09 | 2017-01-05 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,601
-6.9%
16.5526,497 USD |
1,601 -6.9% | 16.55 | 26,497 USD |